Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients

類似資料

• Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study
  著者:: Guerriero, Fabio, 等
  出版事項: (2016)
• Is oxycodone/naloxone effective and safe in managing chronic pain of a fragile elderly patient with multiple skin ulcers of the lower limbs? A case report
  著者:: Guerriero, Fabio, 等
  出版事項: (2015)
• Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy–tolerability pilot study
  著者:: Petrò, Emiliano, 等
  出版事項: (2016)
• Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis
  著者:: Lazzari, Marzia, 等
  出版事項: (2015)
• Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation
  著者:: Lazzari, Marzia, 等
  出版事項: (2016)